Get the Stockscreener App
7.01
3.04%
-0.22
Trevi Therapeutics Inc stock is traded at $7.01, with a volume of 1.61M.
It is down -3.04% in the last 24 hours and down -5.40% over the past month.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
See More
Previous Close:
$7.23
Open:
$7.22
24h Volume:
1.61M
Relative Volume:
0.82
Market Cap:
$853.66M
Revenue:
-
Net Income/Loss:
$-29.07M
P/E Ratio:
-24.17
EPS:
-0.29
Net Cash Flow:
$-31.85M
1W Performance:
-3.38%
1M Performance:
-5.40%
6M Performance:
+59.68%
1Y Performance:
+126.13%
1-Day Range:
$6.93
$7.32
1-Week Range:
$6.93
$7.36
52-Week Range:
$2.36
$8.78
Trevi Therapeutics Inc Stock (TRVI) Company Profile
Name
Trevi Therapeutics Inc
Sector
Industry
Phone
203-304-2499
Address
195 CHURCH STREET, NEW HAVEN, CT
Compare TRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TRVI
Trevi Therapeutics Inc
|
7.01 | 880.45M | 0 | -29.07M | -31.85M | -0.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Initiated | Morgan Stanley | Overweight |
| Jul-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| May-28-25 | Initiated | H.C. Wainwright | Buy |
| Mar-10-25 | Reiterated | Needham | Buy |
| Mar-10-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-12-24 | Reiterated | H.C. Wainwright | Buy |
| Sep-09-24 | Resumed | Leerink Partners | Outperform |
| Aug-30-24 | Initiated | H.C. Wainwright | Buy |
| Aug-30-24 | Initiated | Raymond James | Outperform |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Apr-12-23 | Initiated | B. Riley Securities | Buy |
| Nov-22-22 | Initiated | SVB Leerink | Outperform |
| Jun-03-19 | Initiated | BMO Capital Markets | Outperform |
| Jun-03-19 | Initiated | Needham | Buy |
| Jun-03-19 | Initiated | SVB Leerink | Outperform |
| Jun-03-19 | Initiated | Stifel | Buy |
View All
Trevi Therapeutics Inc Stock (TRVI) Latest News
Using AI based signals to follow Trevi Therapeutics Inc.Buy Signal & Weekly Stock Performance Updates - Newser
What is the target price for Trevi Therapeutics Inc. stockWeekly Stock Analysis & Accurate Intraday Trade Tips - خودرو بانک
What Fibonacci levels say about Trevi Therapeutics Inc. reboundQuarterly Profit Report & Community Verified Watchlist Alerts - Newser
Why Trevi Therapeutics Inc. is moving today2025 Top Decliners & Daily Profit Focused Stock Screening - Newser
Trevi Therapeutics Inc. stock trendline breakdownAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Pattern recognition hints at Trevi Therapeutics Inc. upsideBuy Signal & Safe Capital Investment Plans - Newser
Has Trevi Therapeutics Inc. found a price floorJuly 2025 Selloffs & Expert-Curated Trade Recommendations - Newser
What data driven models say about Trevi Therapeutics Inc.’s futureMarket Rally & Safe Entry Trade Reports - Newser
How does Trevi Therapeutics Inc. score in quality rankingsForecast Cut & Free Reliable Trade Execution Plans - خودرو بانک
Is Trevi Therapeutics Inc. forming a bottoming baseQuarterly Trade Review & Real-Time Market Sentiment Reports - Newser
Volume spikes in Trevi Therapeutics Inc. stock – what they meanMarket Growth Review & Consistent Profit Trading Strategies - Newser
Will Trevi Therapeutics Inc. stock go up soonJuly 2025 PostEarnings & Weekly High Return Opportunities - Newser
Tools to monitor Trevi Therapeutics Inc. recovery probabilityEntry Point & Free Technical Confirmation Trade Alerts - Newser
Visualizing Trevi Therapeutics Inc. stock with heatmapsTrade Analysis Summary & Free Fast Gain Swing Trade Alerts - Newser
Will Trevi Therapeutics Inc. outperform the market in YEARJuly 2025 Movers & Verified Momentum Stock Ideas - خودرو بانک
Can Trevi Therapeutics Inc. hit a new high this monthWeekly Market Report & Advanced Swing Trade Entry Plans - Newser
Can Trevi Therapeutics Inc. reach resistance levels soonJuly 2025 Highlights & Weekly High Return Forecasts - خودرو بانک
Trevi Therapeutics Inc.’s volatility index tracking explainedQuarterly Profit Review & Short-Term High Return Ideas - Newser
Statistical indicators supporting Trevi Therapeutics Inc.’s strengthTrade Entry Report & AI Enhanced Market Trend Forecasts - Newser
Can Trevi Therapeutics Inc. keep up with sector leadersJuly 2025 Fed Impact & Weekly Top Performers Watchlists - خودرو بانک
How to monitor Trevi Therapeutics Inc. with trend dashboards2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Is Trevi Therapeutics Inc. stock reversal real or fakeWeekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Is Trevi Therapeutics Inc. stock ready for a breakoutJuly 2025 Action & Fast Exit and Entry Strategy Plans - Newser
Sentiment analysis tools applied to Trevi Therapeutics Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - Newser
Tools to assess Trevi Therapeutics Inc.’s risk profileTrade Exit Summary & AI Powered Buy/Sell Recommendations - Newser
Will Trevi Therapeutics Inc. benefit from rate cutsMarket Sentiment Summary & AI Powered Market Entry Ideas - خودرو بانک
Volatility clustering patterns for Trevi Therapeutics Inc.Quarterly Profit Report & Community Verified Watchlist Alerts - Newser
Real time breakdown of Trevi Therapeutics Inc. stock performanceWeekly Trend Report & Entry and Exit Point Strategies - Newser
Full technical analysis of Trevi Therapeutics Inc. stockJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Applying chart zones and confluence areas to Trevi Therapeutics Inc.Weekly Volume Report & Technical Analysis for Trade Confirmation - Newser
Signal strength of Trevi Therapeutics Inc. stock in tech scannersEarnings Risk Summary & Weekly Return Optimization Plans - Newser
RSI Reset May Fuel Rebound in Trevi Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Trevi Therapeutics Inc Stock (TRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Trevi Therapeutics Inc Stock (TRVI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Option Exercise |
1.43 |
2,631 |
3,762 |
224,004 |
| SCIASCIA THOMAS | Chief Scientific Officer |
Mar 25 '25 |
Sale |
6.60 |
2,631 |
17,365 |
221,373 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Option Exercise |
1.43 |
5,263 |
7,526 |
218,576 |
| GOOD JENNIFER L | President & CEO |
Mar 21 '25 |
Sale |
6.58 |
5,263 |
34,625 |
213,313 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):